These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6889608

  • 1. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency.
    Russo L, Moore WV.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1003-6. PubMed ID: 6889608
    [Abstract] [Full Text] [Related]

  • 2. A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children.
    Takano K, Shizume K, Hibi I.
    Endocrinol Jpn; 1988 Jun; 35(3):477-84. PubMed ID: 3197659
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP, Vanderschueren-Lodeweyckx M, Maes M, Thiry-Counson G, Craen M, Van Vliet G.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous versus intramuscular growth hormone therapy: growth and acute somatomedin response.
    Wilson DM, Baker B, Hintz RL, Rosenfeld RG.
    Pediatrics; 1985 Sep; 76(3):361-4. PubMed ID: 4034296
    [Abstract] [Full Text] [Related]

  • 5. Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
    Hedin L, Olsson B, Diczfalusy M, Flyg C, Petersson AS, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):962-7. PubMed ID: 8473411
    [Abstract] [Full Text] [Related]

  • 6. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K, Goh M, Sato S, Shimizu Y, Sasaki A, Aida M, Yoshinaga K.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL, Daughaday WH, Weldon VV.
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [Abstract] [Full Text] [Related]

  • 8. Higher plasma somatomedin A (biological) and C (immunological) levels with sc than with im growth hormone replacement therapy.
    Christiansen JS, Kastrup KW, Alberti KG, Petersen KE, Christiansen C, Orskov H.
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):169-72. PubMed ID: 3893007
    [Abstract] [Full Text] [Related]

  • 9. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
    Kohno H, Murakami Y, Kodaira T.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
    [Abstract] [Full Text] [Related]

  • 10. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA, Hassing JM.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [Abstract] [Full Text] [Related]

  • 11. Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.
    Kastrup KW, Christiansen JS, Andersen JK, Orskov H.
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):148-52. PubMed ID: 6637329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.
    Christiansen JS, Orskov H, Binder C, Kastrup KW.
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):6-10. PubMed ID: 6681687
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K, Hizuka N, Shizume K, Honda N, Ling NC.
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [Abstract] [Full Text] [Related]

  • 18. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
    Bozzola M, Lorini R, Schimpff RM, Severi F, Job JC.
    Horm Metab Res; 1986 Apr; 18(4):264-7. PubMed ID: 3710421
    [Abstract] [Full Text] [Related]

  • 19. Early paradoxical decrease in serum somatomedin activity following injection of growth hormone.
    Schimpff RM, Gourmelen M, Donnadieu M, Binoux M, Girard F.
    J Clin Endocrinol Metab; 1978 Jan; 46(1):173-6. PubMed ID: 752020
    [Abstract] [Full Text] [Related]

  • 20. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Short-term effects.
    Wit JM, Van den Brande JL.
    Horm Res; 1984 Jan; 19(4):205-15. PubMed ID: 6745841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.